How long is someone contagious with COVID-19 (Coronavirus Disease 2019) after symptom onset?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of COVID-19 Contagiousness After Symptom Onset

Most individuals with mild-to-moderate COVID-19 are contagious for approximately 10 days after symptom onset, though two-thirds remain infectious at day 5 and nearly one-quarter at day 7. 1

Infectious Window Timeline

The contagious period begins 1-2 days before symptoms appear, making pre-symptomatic transmission a critical feature of COVID-19 spread. 1 This distinguishes COVID-19 from many other respiratory infections and explains its rapid pandemic transmission. 1

Peak viral shedding occurs within the first 7 days of illness, with viral titers highest during this early phase. 1 Live virus remains detectable in the respiratory tract for up to 9 days in most individuals. 1

Duration by Disease Severity

Mild-to-Moderate Cases

  • Median duration: 5 days after symptom onset, though this represents when half of patients are no longer infectious. 1
  • Viral shedding continues for 1-2 weeks in most mild-moderate cases. 1
  • By day 10, most patients are no longer infectious, with studies showing that COVID-19 patients with mild-to-moderate illness are highly unlikely to be infectious beyond 10 days of symptoms. 2
  • Contact tracing studies found no evidence of transmission when close contacts were first exposed more than 5 days after symptom onset in the index case. 2

Severe-to-Critical Cases

  • Viral shedding extends beyond 2 weeks in severe cases. 1
  • Contagiousness can extend up to 15 days for those with severe/critical COVID-19. 1, 3
  • Viral viability has been documented up to 20 days from symptom onset in some severe cases. 1, 3, 4
  • In virus culture studies of severe/critical disease, SARS-CoV-2 was isolated up to day 32 in one study. 2

Immunocompromised Patients

  • Prolonged viral shedding occurs, with quarantine extending to at least 20 or more days following symptom onset. 1
  • Replication-competent virus isolated for up to 20 days in immunocompromised patients. 2
  • Contagiousness can extend up to 15 days or longer in this population. 3

Practical Isolation Recommendations

For symptomatic patients with mild-moderate disease:

  • Continue isolation until at least 10 days have passed since symptom onset. 1, 3
  • Additionally, ensure at least 3 days have passed since recovery (defined as resolution of fever without fever-reducing medications and improvement in respiratory symptoms). 1, 3

For patients with persistent symptoms beyond day 7 and positive testing:

  • Continue isolation, as this combination indicates active infection and potential infectiousness. 1, 3
  • The presence of both ongoing symptoms and a positive test strongly suggests continued viral replication. 3

For immunocompromised or severe/critical cases:

  • Extend isolation to at least 20 days following symptom onset. 1

Common Pitfalls

PCR testing limitations: PCR tests may remain positive for extended periods (up to 30 days) even after a person is no longer infectious, due to detection of non-viable viral fragments. 3 However, ongoing symptoms combined with positive testing suggests active infection rather than just residual viral RNA. 3

Antigen testing correlation: Nucleocapsid (N) antigen testing is a strong predictor of viral infectiousness (relative risk=7.61 for culture positivity) and may be more suitable than viral RNA or symptom assessment alone for determining when to discontinue isolation within two weeks from symptom onset. 5

Asymptomatic transmission: Approximately 30-60% of patients shedding virus may have no symptoms, making asymptomatic transmission a significant concern throughout the infectious period. 1

References

Guideline

COVID-19 Infectious Window and Transmission

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

COVID-19 Contagiousness Beyond Symptom Onset

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Research

Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.